Lasa Supergenerics has announced a board meeting where it approved the financial results for the quarter and half-year. A major update from the auditor's report highlights a significant fire on May 15, 2025, at its main factory. This incident caused an uninsured loss of approximately Rs 12.74 Cr in inventory, Rs 7.00 Cr in assets, and Rs 0.84 Cr in other expenses, halting all production. The company faces challenges resuming operations and is exploring contract manufacturing or leasing to address going concern issues. Investors should note this operational disruption.